Figure 6
From: BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer
BCL2A1 protein if only expressed after CHCP treatment in TNBC cells. Expression of BCL2A1 after CAP treatment (CP) and mock controls (M) in TNBC cell line MDA-MB-231. Representative Western blots (A) and bar graph representation (B) of the quantification of BCL2A1 protein in total tissue lysates from MDA-MB-231 cells after CHCP treatment compared to the mock control groups.
